New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 19, 2014
10:00 EDTJBHT, CX, CVBF, SAIA, GOGO, CPST, PAAS, CCMP, MTB, G, RHT, SNI, ACT, AHTOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Actavis (ACT) upgraded to Buy from Neutral at Goldman... Ashford Hospitality (AHT) upgraded to Outperform from Neutral at RW Baird... CEMEX (CX) upgraded to Buy from Neutral at Sterne Agee... Capstone Turbine (CPST) upgraded to Outperform from Market Perform at FBR Capital... Genpact (G) upgraded to Buy from Neutral at Citigroup... Gogo (GOGO) upgraded to Overweight from Equal Weight at Evercore... J.B. Hunt (JBHT) upgraded to Buy from Hold at Wunderlich... M&T Bank (MTB) upgraded to Buy from Neutral at SunTrust... Saia, Inc. (SAIA) upgraded to Buy from Hold at Wunderlich... Scripps Networks (SNI) upgraded at Argus... Cabot Microelectronics (CCMP) upgraded at DA Davidson... CVB Financial (CVBF) upgraded to Outperform from Market Perform at Fig Partners... Red Hat (RHT) upgraded to Outperform from Market Perform at Cowen... Pan American Silver (PAAS) upgraded to Market Perform from Underperform at BMO Capital.
News For ACT;AHT;CPST;CX;G;GOGO;JBHT;MTB;SAIA;SNI;CCMP;CVBF;RHT;PAAS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
March 17, 2015
08:59 EDTACTActavis sees combined annual pro forma revenues of over $23B in 2015
Subscribe for More Information
08:58 EDTACTActavis sees double digit accretion to adjusted EPS within first 12 months
08:58 EDTACTActavis says will 'immediately begin implementing' integration plans
Subscribe for More Information
08:57 EDTACTActavis completes acquisition of Allergan
Actavis plc (ACT) announced that it has completed the acquisition of Allergan (AGN) in a cash and equity transaction valued at approximately $70.5B. The combination creates one of the world’s top 10 pharmaceutical companies by sales revenue, with combined annual pro forma revenues of more than $23B anticipated in 2015. Actavis continues to expect the transaction to generate double-digit accretion to non-GAAP earnings within the first 12 months, including approximately $1.8B in operating and financial synergies to be realized within one year following the close. These synergies exclude any additional revenue or manufacturing synergies, and are in addition to the $475M of annual savings previously announced by Allergan in connection with Project Endurance. Actavis further expects to generate strong operating cash flow in excess of $8B in 2016, which would enable the company to rapidly de-lever the balance sheet.
08:56 EDTACTActavis completes Allergan acquisition valued at $70.5B
Subscribe for More Information
08:49 EDTSNIScripps acquisition of Polish business difficult to understand, say Bernstein
Subscribe for More Information
08:06 EDTGGenpact expands partnership with Exilant
Subscribe for More Information
07:48 EDTSNIScripps to meet with BBC Trust over GBP500M offer for UKTV stake, Guardian says
Subscribe for More Information
March 16, 2015
18:38 EDTACTAmerican Airlines to replace Allergan in S&P 500 as of 3/20 close
Subscribe for More Information
16:10 EDTACTActavis receives FDA approval for VIIBRYD 20mg once daily
Subscribe for More Information
10:22 EDTACTEuropean Commission clears Actavis' pending acquisition of Allergan
Subscribe for More Information
10:02 EDTCCMPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:09 EDTJBHTJ.B. Hunt has several positive catalysts, says Bernstein
Subscribe for More Information
06:47 EDTCCMPCabot Microelectronics downgraded to Hold from Buy at Needham
Needham downgraded Cabot Microelectronics based on valuation, estimate risk from lower PC demand, and limited capital returns and growth.
06:04 EDTSNIScripps Networks to host conference call
Subscribe for More Information
05:19 EDTSNIScripps Networks to acquire controlling interest in Polish TV operator TVN
Scripps Networks has entered into an agreement to acquire a 52.7% interest in Poland’s premier multi-platform media company, TVN. The company has agreed to acquire the stake from ITI and Canal+ Group for an all-cash consideration of EUR 584M. Scripps Networks Interactive will also assume EUR 840M of debt. The agreement is subject to regulatory approvals. Following completion, Scripps Networks Interactive will launch a mandatory public tender offer to further increase its ownership interest in TVN, as required under Polish law.
March 13, 2015
17:33 EDTACTS&P announces changes to S&P 100 Index
Subscribe for More Information
08:03 EDTACTActavis receives FDA approval SAPHRIS for pediatric patients
Actavis announced that the FDA has approved its supplemental new drug application for SAPHRIS as monotherapy for the acute treatment of manic or mixed episodes associated with bipolar I disorder in pediatric patients. SAPHRIS is the only atypical antipsychotic treatment option with a sublingual formulation. The FDA approval of SAPHRIS is based on the results of a 3-week monotherapy trial in 403 pediatric patients, of which 302 pediatric patients received SAPHRIS twice daily in doses of either 2.5 mg, 5 mg or 10 mg. SAPHRIS was shown to demonstrate improvement in Young Mania Rating Scale total score and Clinical Global Impression-Bipolar Severity of Illness overall score versus placebo in a pediatric clinical trial.
March 12, 2015
13:22 EDTRHTRed Hat April volatility elevated into Q4 and outlook
Red Hat March call option implied volatility is at 25, April is at 35, June is at 29, September is at 26; compared to its 26-week average of 31 according to Track Data, suggesting large April price movement into the expected release of Q4 results on March 25.
08:28 EDTMTBM&T Bank receives no objection to its 2015 capital plan
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use